:

Stefan Nowak1, Dany Jaffuel1, Jacques Morel2

  • 1Department of Respiratory Disease, PhyMedExp, University of Montpellier, INSERM U1046, CNRS UMR 9214, CHU Montpellier, Montpellier, France.

概括

确定了全身性硬化症患者组,揭示了不同的临床表现和预后. 肺高血压在这些已识别的全身性硬化症队伍中显著影响了生存率.